Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,233 | 861 | 349 | 2,252 | 1,926 |
| Gross Profit | 1,233 | 861 | 349 | 2,252 | 1,926 |
| Operating Expenses | 3,370 | 5,122 | 4,958 | 6,113 | 4,326 |
| Operating Income | -2,137 | -4,261 | -4,609 | -3,861 | -2,400 |
| Other Income | 138 | 245 | 163 | 74 | 92 |
| Pre-tax Income | -1,999 | -4,016 | -4,446 | -3,788 | -2,308 |
| Net Income Continuous | -1,999 | -4,016 | -4,446 | -3,838 | -2,308 |
| Net Income | $-1,999 | $-4,016 | $-4,446 | $-3,838 | $-2,308 |
| EPS Basic Total Ops | -0.12 | -0.29 | -0.40 | -0.41 | -0.26 |
| EPS Basic Continuous Ops | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 |
| EPS Diluted Total Ops | -0.12 | -0.29 | -0.40 | -0.41 | -0.26 |
| EPS Diluted Continuous Ops | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 |
| EBITDA(a) | $-2,137 | $-4,261 | $-4,609 | $-3,861 | $-2,400 |